Article Listing - Positive opinions for Novartis' Jetrea and Ilaris from EMA advisory panel

EC PHARMA MARKET LURCHES TO COMPLETION

20 April 1992

The complex issue of creating a unified drug marketing approval regime in the European Comm-unity internal market is outlined in...

SLIGHT RISE IN UCB PRETAX PROFITS

20 April 1992

The Belgian UCB chemical and pharmaceutical group UCB announced a slight rise of 1% in pretax ordinary profits for 1991...

US SENATE PASSES DEBARMENT BILL

20 April 1992

The US Senate passed HR 2454, the Generic Drug Enforcement Act, with some amendments, just before Congress broke for the...

DRUG REVIEW PLAN SETS FOUR INITIATIVES

20 April 1992

Four initiatives are to be implemented by the US Food and Drug Administration to speed access to new drugs and...

STOCK MARKET COMMENTARY: NEW YORK

20 April 1992

NEW YORK: having lost heavily for the first two reporting days, the Dow Jones failed to close the week...

CELTRIX' THOMAS DAVIS

20 April 1992

Thomas Davis is elected to the board of directors at Celtrix Pharmaceuticals.

NEW DIRECTOR AT ABBOTT LABS

20 April 1992

Abbott Laboratories has appointed Addison Barry Rand, executive vice president of Xerox Corp, as a director.

CHINESE ARTHRITIS REMEDY UNDER TEST

20 April 1992

Researchers at the University of Texas Southwestern Medical Center in the USA have applied to the US Food and Drug...

DO ANTIHISTAMINES WORK FOR COLDS?

20 April 1992

The US Food and Drug Administra-tion is to reconsider the labelling claims for over-the-counter antihistamines, which suggest the products may...

SUSPENSION OF DPT VACCINE

13 April 1992

Following the decision by the Department of Health in the Republic of China for an immediate temporary suspension of the...

Showing 94491-94500 of 95579 articles

Go to beginningPreviousNextGo to end